T

TiumBio Co Ltd
KOSDAQ:321550

Watchlist Manager
TiumBio Co Ltd
KOSDAQ:321550
Watchlist
Price: 5 790 KRW 5.27% Market Closed
Market Cap: ₩160.3B

Net Margin

-125.8%
Current
Improving
by 172.5%
vs 3-y average of -298.3%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-125.8%
=
Net Income
₩-11.7B
/
Revenue
₩9.3B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-125.8%
=
Net Income
₩-11.7B
/
Revenue
₩9.3B

Peer Comparison

Country Company Market Cap Net
Margin
KR
TiumBio Co Ltd
KOSDAQ:321550
157.2B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
387B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.5B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
174.7B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.5B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.2B USD
Loading...
AU
CSL Ltd
ASX:CSL
86.9B AUD
Loading...
NL
argenx SE
XBRU:ARGX
44B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Lower than 95% of companies in Korea
Percentile
5th
Based on 2 632 companies
5th percentile
-125.8%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

TiumBio Co Ltd
Glance View

Market Cap
160.3B KRW
Industry
Biotechnology

TiumBio Co., Ltd. engages in the development and manufacture of therapeutic drugs. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2019-11-22. The firm researches and develops small molecule drugs including endometriosis treatments, uterine fibroids treatments, cancer immunotherapy drugs; and new biopharmaceuticals including hemophilia treatments, and others.

Intrinsic Value
6 180.31 KRW
Undervaluation 6%
Intrinsic Value
Price
T
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-125.8%
=
Net Income
₩-11.7B
/
Revenue
₩9.3B
What is TiumBio Co Ltd's current Net Margin?

The current Net Margin for TiumBio Co Ltd is -125.8%, which is above its 3-year median of -298.3%.

How has Net Margin changed over time?

Over the last 3 years, TiumBio Co Ltd’s Net Margin has increased from -835.7% to -125.8%. During this period, it reached a low of -835.7% on Aug 30, 2022 and a high of -125.8% on Oct 30, 2025.

Back to Top